InvestorsHub Logo
Followers 12
Posts 1303
Boards Moderated 0
Alias Born 10/21/2006

Re: None

Friday, 04/22/2011 10:40:08 AM

Friday, April 22, 2011 10:40:08 AM

Post# of 890
http://www.marketwatch.com/story/biogen-shares-surge-after-ms-drug-study-2011-04-21?siteid=yhoof
Interesting brief article and comments re: Biogen's BG-12 Phase 3 trials.
Since BG-12 could cut into future sales of all present MS drugs including Elan's, they need to hope that it works better than Pfizer's attempt at taking the oral route of administering the drug.